Advanced search
Publication Cover
Journal of Hepatocellular Carcinoma Volume 9, 2022 - Issue
Submit an article Journal homepage
96
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma

Ahmed O Kaseb1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
,
Yinghui Guan2 Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, CA, USAView further author information
,
Betul Gok Yavuz1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Alexander R Abbas2 Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, CA, USAView further author information
,
Shan Lu2 Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, CA, USAView further author information
,
Elshad Hasanov3 Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-7195-0842View further author information
ORCID Icon,
Han Chong Toh4 Division of Medical Oncology, National Cancer Centre Singapore, Singapore, SingaporeView further author information
,
Wendy Verret5 Product Development, Genentech Inc, South San Francisco, CA, USAView further author information
&
Yulei Wang2 Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9057-9786View further author information
ORCID Icon show all
Pages 1065-1079 | Received 22 Apr 2022, Accepted 16 Jul 2022, Published online: 11 Oct 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

James Yu, Robin Park & Richard Kim. (2023) Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights. Journal of Hepatocellular Carcinoma 10, pages 1105-1127.
Read now

Articles from other publishers (2)

Ji Won Han & Jeong Won Jang. (2023) Predicting Outcomes of Atezolizumab and Bevacizumab Treatment in Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences 24:14, pages 11799.
Crossref
Neda Minaei, Roya Ramezankhani, Atena Tamimi, Abbas Piryaei, Ali Zarrabi, Amir Reza Aref, Ebrahim Mostafavi & Massoud Vosough. (2023) Immunotherapeutic approaches in Hepatocellular carcinoma: Building blocks of hope in near future. European Journal of Cell Biology 102:1, pages 151284.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.